Skip to main content

Month: February 2024

Titan NRG (TTNN) Announces Record Profits for Third Quarter Fiscal 2023

TUCSON, AZ, Feb. 20, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — Titan NRG, Inc. (OTCPK: TTNN) (the “Company”), a leader in integrated downstream energy and transportation holding company, today announced results for its third quarter fiscal 2023 ended December 31, 2023. While much of the country experienced unseasonably warm weather during the October-through-December period, Titan NRG showcased its resiliency, efficiency, and growth trajectory to generate a net profit in quarter 3 of Fiscal 2023. Highlights from the quarterly report include:$2.3 million in revenue $1.04 million in gross profit $130,624 in net profit $6.3 million in capital assets (before depreciation) $905,520 cash on hand as of December 31, 2023Operational highlights for the quarter include:15 million plus gallons of liquefied petroleum gas transported Over...

Continue reading

BIO-key Receives $1.5M Pre-Paid, Two-Year Software Subscription Order for its Biometric Identification Platform

Over 25 Million Clients Authenticate with BIO-key HOLMDEL, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) — BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) software infrastructure featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication solutions, announced that a long-term financial services customer has executed a two-year, pre-paid $1.5 million agreement for the ongoing use and expanded deployment of BIO-key’s biometric customer identification technology. The agreement follows continued strong growth in client enrollments by the customer over eight years since its first deployment. The BIO-key system streamlines and enhances security for the client identification process for over 25 million clients and contemplates...

Continue reading

Ascot Provides Construction Update on the Premier Gold Project

Figure 1Visible gold in quartz vein found in ore drive 6 at Big MissouriFigure 2TSF overview looking southFigure 3TSF South and Southeast dams completeFigure 4WTP commissioningFigure 5WTP MBBR systemFigure 6Mill piping over 90% completeFigure 7Premier underground portal overheadFigure 8Premier underground portal front viewFigure 9Mill area overviewVANCOUVER, British Columbia, Feb. 20, 2024 (GLOBE NEWSWIRE) —  Ascot Resources Ltd. (TSX: AOT; OTCQX: AOTVF) (“Ascot” or the “Company”) is pleased to provide a construction update on the Company’s Premier Gold Project (“PGP” or the “Project”), located on Nisga’a Nation Treaty Lands in the prolific Golden Triangle of northwestern British Columbia. Project construction was 86% complete as of December 31, 2023...

Continue reading

HYTN Broadens Reach with Innovative Cannabis-Infused Nano Shot

VANCOUVER, British Columbia, Feb. 20, 2024 (GLOBE NEWSWIRE) — HYTN Innovations Inc. (CSE: HYTN “HYTN or The Company“), a leader in the cannabis sector known for specialized psychoactive and psychotropic product development, is excited to announce the expansion of its 100 mg Nano Shot Citrus (“Nano Shot”) to the key markets of British Columbia and Alberta. Following its initial success in Ontario, Canada’s largest market, this move represents a significant stride in the company’s national distribution goals. “The enthusiasm from the western provinces for Nano Shot has been remarkable,” stated HYTN Chief Executive Officer, Elliot McKerr. “Introducing our distinctive Nano Shot product line to these vibrant markets highlights HYTN’s dedication to innovation and quality. We are committed...

Continue reading

PharmAla Data to be Published in ACS Chemical Neuroscience

Scientific Journal Article follows notable IP updates, including publication of key PCT Patent Application, presentation at International Society for Research into Psychedelics Conference VANCOUVER, British Columbia, Feb. 20, 2024 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased that data from its computational Drug Discovery program, in conjunction with the University of Waterloo (laboratory of Dr. James Gauld) and made possible by funding from MITACS, will be published in the scientific journal ACS Chemical Neuroscience this week. The article “Exploring Structure-Activity Relationships in Phenethylamines:...

Continue reading

Aemetis Announces Updated Five Year Plan Projecting Growth to $1.95 Billion of Revenue and $645 Million of Adjusted EBITDA in 2028

CUPERTINO, CA, Feb. 20, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable fuels company focused on negative carbon intensity products, today announced an updated Aemetis Five Year Plan (the “2024 Plan”) that projects the company will generate $1.95 billion in revenues and $645 million of adjusted EBITDA in year 2028.  The 2024 Plan states revenues are expected to grow at a compound annual growth rate of 38%, and adjusted EBITDA is expected to grow at a projected compound annual growth rate of 83% for the years 2024 to 2028. A presentation summarizing the updated Five Year Plan is available for review on the Aemetis website at www.aemetis.com/Five-Year-Plan. In the Aemetis 2024 Five Year Plan, the Company’s revenue and adjusted EBITDA growth is expected from 75 dairies...

Continue reading

Neuronetics to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call

MALVERN, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced that it plans to release fourth quarter 2023 financial and operating results prior to market open on Tuesday, March 5th, 2024. The Company will host a conference call to review its results at 8:30 a.m. Eastern Time the same day. The conference call will be broadcast live in listen-only mode via webcast at https://edge.media-server.com/mmc/p/7cha7jae. To listen to the conference call on your telephone, participants may register for the call here. While it is not required, it is recommended you join 10 minutes prior to the event start. About Neuronetics Neuronetics, Inc....

Continue reading

Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease

WATERTOWN, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that the United States Food and Drug Administration (FDA) has granted Fast Track Designation to DISC-0974 for the treatment of patients with non-dialysis dependent chronic kidney disease (NDD-CKD) and anemia. “Receiving Fast Track designation highlights the unmet need for the millions of NDD-CKD patients with anemia, as well as the potential of DISC-0974 to address this need,” said John Quisel, J.D., Ph.D., President and Chief Executive Officer of Disc. “We believe DISC-0974 could be a transformative therapy for these patients and are excited to share...

Continue reading

Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® to Maine Dental Group, a Premier Group Practice with 21 Locations Across the Northeast

ROSELAND, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announces it has commenced sales of its STA Single Tooth Anesthesia System® (STA) with Maine Dental Group, a premier group of 21 dental practices across the northeastern United States. Arjan Haverhals, Chief Executive Officer of Milestone Scientific, noted, “We are honored to add Maine Dental Group to our growing roster of dental practices, and believe this agreement is further validation of our new direct sales model, as well as our emphasis on Dental Service Organizations (DSOs) and large group practices, which we initiated last year. We are executing our new sales strategy, which allows us to leverage a lean sales organization,...

Continue reading

CarbonMeta Technologies Wins Sole Source Contract with Saudi Investment Recycling Company (SIRC)

CarbonMeta and SIRC to launch cement-less concrete pilot project in March 2024 Riyadh, Saudi Arabia and Woodinville, WA, USA, Feb. 20, 2024 (GLOBE NEWSWIRE) — CarbonMeta Technologies Inc. (OTC PINK:COWI, “CarbonMeta”) announced today that it has won an 850,000 SAR (220,000 USD) sole source contract with Saudi Investment Recycling Company (SIRC) to develop and commercialize a carbon-negative concrete made from industrial, construction demolition waste and mining waste, and thereby provide sustainable, eco-friendly products for strategic construction projects in the Kingdom of Saudi Arabia (KSA). SIRC, a wholly owned subsidiary of the Saudi Public Investment Fund (PIF) of Saudi Arabia plans to attract over $13 billion in foreign direct investment and contribute over $30 billion to Saudi GDP by 2035, by investing in key technologies...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.